RESEARCH-USE BIOSIMILAR ANTIBODY

Tusamitamab

Antibody-drug conjugate · IgG1

CEAIgG1RUO

Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize ADC Tusamitamab ravtansine (SAR408701) (HY-P99542).

TARGETCEA
YAntibody-drug conjugate
CATALOGSC-BS-072
CATALOG NUMBERSC-BS-072
MOLECULAR WEIGHTApprox. 144.76 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize ADC Tusamitamab ravtansine (SAR408701) (HY-P99542).

Tusamitamab is a recombinant research-use antibody directed against CEA.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tusamitamab | StellaCyte